Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
590
-
Total 13F shares, excl. options
-
183M
-
Shares change
-
+95.7M
-
Total reported value, excl. options
-
$14.4B
-
Value change
-
+$7.51B
-
Put/Call ratio
-
0.42
-
Number of buys
-
520
-
Number of sells
-
-88
-
Price
-
$78.98
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2015
660 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q4 2015.
Edwards Lifesciences Corp - Common Stock (EW) has 590 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 183M shares
of 590M outstanding shares and own 30.95% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18.3M shares), SANDS CAPITAL MANAGEMENT, LLC (10.9M shares), FMR LLC (9.27M shares), STATE STREET CORP (9.19M shares), Capital Research Global Investors (8.56M shares), WELLINGTON MANAGEMENT GROUP LLP (6.89M shares), BlackRock Institutional Trust Company, N.A. (5.44M shares), BlackRock Fund Advisors (4.01M shares), Winslow Capital Management, LLC (3.56M shares), and AQR CAPITAL MANAGEMENT LLC (3.11M shares).
This table shows the top 590 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.